GPN Vaccines
About:
GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.
Website: https://gpnvaccines.com/
Twitter/X: GPNVaccines
Top Investors: National Health and Medical Research Council, Shearwater Capital, Forepont Capital Partners, Government of South Australia, Kern Whelan Capital
Description:
GPN Vaccines is a clinical stage biotechnology company developing a Streptococcus pneumoniae vaccine. The company's vaccine is designed to prevent life-threatening pneumonia, bacteremia, and meningitis, as well as otitis media.
Total Funding Amount:
36.1M AUD
Headquarters Location:
Adelaide, South Australia, Australia
Founded Date:
2017-09-19
Founders:
Tim Hirst
Number of Employees:
11-50
Last Funding Date:
2024-06-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai